NEWS ROOM

November 1, 2019

4BIO's Dmitry Kuzmin and Owen Smith enjoyed speaking to Natalie Grover at Endpoints on the state of cell & gene therapy trials in Europe and the US fo...

March 24, 2018

TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) and Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) today announced that the E...

December 19, 2017

Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced tod...

Please reload

ARCHIVE
Please reload

SEARCH BY TAGS
Please reload

FOLLOW US
4BIO CAPITAL is a trade name of 4BIO Ventures Management Ltd, which is authorised and regulated by the Financial Conduct Authority, register number 775193
© 2015-2020 by 4BIO Ventures Management Ltd